Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

This study has been terminated.
National Cancer Institute (NCI)
Information provided by:
Sidney Kimmel Comprehensive Cancer Center Identifier:
First received: November 1, 1999
Last updated: July 19, 2011
Last verified: April 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2010
  Primary Completion Date: October 2001 (Final data collection date for primary outcome measure)